cystamine has been researched along with haloperidol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dhandapani, KM; Mahadik, SP; Pillai, A; Veeranan-Karmegam, R | 1 |
| Clark, JD; Dill, DL; Giffard, R; Nishimura, T; Nishimura, Y; Peltz, G; Sahbaie, P; Wu, M; Xiong, X; Xu, D; Xu, LJ; Zhang, H; Zheng, M | 1 |
2 other study(ies) available for cystamine and haloperidol
| Article | Year |
|---|---|
Cystamine prevents haloperidol-induced decrease of BDNF/TrkB signaling in mouse frontal cortex.
Topics: Analysis of Variance; Animals; Brain-Derived Neurotrophic Factor; Cell Survival; Cells, Cultured; Cystamine; Dopamine Antagonists; Drug Interactions; Embryo, Mammalian; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Frontal Lobe; Gene Expression Regulation; Glutathione; Haloperidol; Male; Mice; Neurons; Receptor, trkB; Signal Transduction; Time Factors | 2008 |
A Pharmacogenetic Discovery: Cystamine Protects Against Haloperidol-Induced Toxicity and Ischemic Brain Injury.
Topics: Amidohydrolases; Animals; Antipsychotic Agents; Brain Ischemia; Cell Adhesion Molecules; Cystamine; GPI-Linked Proteins; Haloperidol; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Pharmacogenetics; Polymorphism, Single Nucleotide | 2016 |